Roxadustat

罗沙司他

Report date: 2026/03/06 20:02:51
NMEFirst In Class

Base Information

Drug NameRoxadustat
Drug Alias NameRoxadustatum诺德司他可博美Heterocyclic carboxamide洛度司他 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitors
TargetsHypoxia-inducible factor prolyl hydroxylase
Therapy Area/IndicationsAnxiety DisordersMyelodysplastic SyndromesAnemia +[10] 
Global Approved IndicationsAnemia
Approved Indications in ChinaAnemia
Original Approved Country/TerritoryMainland China
Original Approved Date2018/12/17
Country/TerritoryCzechiaBelgiumBulgaria +[65] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesFibrogen Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesMansoura UniversityFibrogen IncAstellas Pharma Europe Bv +[7] 
Inactive CompaniesAstellas Pharma Inc
Active IndicationsAnxiety DisordersMyelodysplastic SyndromesAnemia +[8] 
Inactive IndicationsRenal InsufficiencyHepatic Insufficiency

Other Information

ATC CodeB03XA05
Related LinksKEGG